Development and validation of an m6A RNA methylation regulator-based signature for the prediction of prognosis and immunotherapy in cutaneous melanoma
Main Authors: | Tingting Li, Xiaoyue Zhang, Caroline Wang, Qiuyu Jia, Lingzhi Zhong, Jian Hu, Houmin Li, Jianzhong Zhang, Lishao Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2023-11-01
|
Series: | Chinese Medical Journal |
Online Access: | http://journals.lww.com/10.1097/CM9.0000000000002599 |
Similar Items
-
Identification and Validation of Ferroptosis-Related DNA Methylation Signature for Predicting the Prognosis and Guiding the Treatment in Cutaneous Melanoma
by: Wenna Guo, et al.
Published: (2022-12-01) -
Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma
by: Yujian Xu, et al.
Published: (2022-07-01) -
Leveraging a disulfidptosis-related signature to predict the prognosis and immunotherapy effectiveness of cutaneous melanoma based on machine learning
by: Yi Zhao, et al.
Published: (2023-10-01) -
Senescence-Related lncRNA Signature Predicts Prognosis, Response to Immunotherapy and Chemotherapy in Skin Cutaneous Melanoma
by: Kefan Lin, et al.
Published: (2023-04-01) -
Leveraging a cuproptosis-based signature to predict the prognosis and drug sensitivity of cutaneous melanoma
by: Da Liu, et al.
Published: (2023-01-01)